Boston Scientific : Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System

Chief Editor October 5, 2015 0 10 sec read

MARLBOROUGH, Mass., Oct. 5, 2015 /PRNewswire/ — Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.

Posted: 2015-10-05 12:44:00

Read all

Chief Editor

View More Posts

Previous Article Merkel critics seek limit on refugee numbers Conservative allies of German Chancellor Angela Merkel have called for a refugee limit, as a paper predicts 1.5 million arrivals this year. Speaking on public radio, Merkel stressed that the country will be abl

Next Article Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

Global Investors Summit | Industry captains promise more: ‘Investors can see change in UP’

Promising big-ticket investments in Uttar Pradesh during the Global Investors Summit in Lucknow on Friday, leading business conglomerates of the country assured the government to […]

February 11, 2023 0 36 sec read

Why Logitech’s Steam Deck rival is too ahead of its time

The Logitech G Cloud is a new handheld streaming console that looks a little too forward-thinking in our age of poor public Wi-Fi. Now fully […]

September 22, 2022 0 40 sec read

Going to Disney? How to Handle the Parks’ New Pricing

The 1-day ticket price calendar for Disneyland in April, for example, shows “Peak” pricing will be in effect through April 10th — when many schools […]

March 5, 2016 0 15 sec read

First Reserve Appoints Alex Krueger as Co-CEO

GREENWICH, Conn. HOUSTON LONDON , and HONG KONG, Feb. 16, 2015 /PRNewswire/ — First Reserve, the largest global private equity and infrastructure investment firm exclusively […]

February 16, 2015 0 13 sec read

All Media Info